Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000740:Anemia / Q000139:chemically induced; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D007962:Leukocytes / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009113:Muramidase / Q000097:blood; D009325:Nausea / Q000139:chemically induced; D012075:Remission, Spontaneous; D012737:Sex Factors; D013866:Thioguanine / Q000008:administration & dosage / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D004273:DNA, Neoplasm; D003561:Cytarabine; D009113:Muramidase; D013866:Thioguanine